29.07.2013 - Swiss drugmaker Novartis won an important endorsement of its new inhaled medicine for chronic lung disease on Friday when European regulators recommended approval of Ultibro...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)